Standardization of result reporting in pathomorphological examination of prostate biopsy specimens
- Authors: Prilepskaya E.A.1, Kovylina M.V.1, Pushkar D.Y.1, Reshetov L.V.1
-
Affiliations:
- A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
- Issue: Vol 2, No 1-2 (2019)
- Pages: 47-51
- Section: Methodical materials and practical recommendations
- Published: 07.03.2019
- URL: https://oncopathology.abvpress.ru/2618-7019/article/view/708426
- DOI: https://doi.org/10.17650/2618-7019-2019-2-1-2-47-51
- EDN: https://elibrary.ru/GRQAWL
- ID: 708426
Cite item
Full Text
Abstract
Prostate cancer (PCa) is one of the most common malignancies in middle-aged and elderly men. We observe a trend toward increasing incidence of PCa in the USA, Europe, and Russia. Treatment of PCa patients is largely based on the results of transrectal multifocal prostate biopsy, which is considered to be the gold standard for PCa diagnostics. Therefore, there is a clear need for standardization of the result reporting system used in pathomorphological examination of prostate biopsy specimens. This article describes the principles of tumor grading, processing of biopsy samples, and the requirements for standard pathomorphological reports.
About the authors
E. A. Prilepskaya
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia
Author for correspondence.
Email: prilepskayae@mail.ru
Moscow, Russia
M. V. Kovylina
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaMoscow, Russia
D. Yu. Pushkar
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaMoscow, Russia
L. V. Reshetov
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of RussiaMoscow, Russia
References
- Горбань Н.А., Кудайбергенова А.Г. Трепанобиопсия предстательной железы: взгляд морфолога. М.: ИД "АБВ-пресс", 2017. 152 с.
- Srigley J.R., McGowan T., MacLean A. et al. Standardized synoptic cancer pathology reporting: A population based approach. J Surg Oncol 2009;99(8):517-24. PMID: 19466743. doi: 10.1002/jso.21282.
- AJCC Cancer Staging Manual. Eds.: S.E. Edge, D.R. Byrd, C.C.Compton et al. 7th edn. New York: Springer, 2010. 718 p.
- Amin M.B., Lin D.W., Gore J.L. et al. The critical role of the pathologist in de termining eligibility for active surveillance as a management option in patients with prostate cancer. Arch Pathol Lab Med 2014;138(10):1387-405. PMID: 25092589. DOI: 10.5858/ arpa.2014-0219-SA.
- Epstein J.I., Allsbrook W.C.J., Amin M.B., Egevad L.L. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005;29(9):1228-42. PMID: 16096414.
- Protocol for the examination of specimens from patients with carcinoma of the prostate gland. Version: Prostate 4.0.1.0, protocol posting date: June 2017. Includes pTNM requirements from the 8th edition, AJCC Staging Manual. College of American Pathologists.
- RCPA (Royal College of Pathologists of Australasia). Guidelines for Authors of Structured Cancer Pathology Reporting Protocols. RCPA, Surry Hills NSW, 2016.
- Amin M.B. Diagnostic pathology genitourinary. Lippincott Williams & Wilkins, 2010.900 p.
- Epstein J.I. The Gleason grading system: a complete guide for pathologist and clinicians. Lippincott Williams & Wilkins, 2013. 224 p.
- WHO (World Health Organization). World Health Organization classification of tumours. Pathology and genetics of tumours of the urinary system and male genital organ. Eds.: H. Moch, P.A. Humphrey, T.M. Ulbright, V.E. Reuter. Lyon: IARC Press, 2016.
Supplementary files
